M10.48
Other secondary gout, vertebrae
Clinical Classification Guidelines
Medical Intelligence & Overview
Other secondary gout in the vertebrae, classified under ICD-10 code M10.48, is a form of gout that affects the spinal bones rather than the more common joints like the toes or knees. Unlike primary gout, which results from a primary metabolic disorder, secondary gout arises due to secondary causes that lead to elevated uric acid levels. When gout impacts the vertebrae, it can cause significant discomfort and complications, especially if left untreated. Recognizing and understanding this condition is vital for proper management and improving quality of life.
Causes & Symptoms
Clinical Causes: Chronic renal failure or kidney disease, leading to reduced uric acid excretion. Use of certain medications such as diuretics or low-dose aspirin, which can elevate uric acid levels. Metabolic syndromes or disorders that increase uric acid production. Prolonged exposure to high levels of alcohol which can interfere with uric acid clearance. Other underlying health conditions, such as certain blood disorders or infections, that predispose individuals to secondary gout.
Key Symptoms: Persistent or intermittent back pain localized in the area of affected vertebrae. Swelling and redness over the affected spinal region. Stiffness and limited range of motion in the back. Potential neurological symptoms like numbness, tingling, or weakness if nerve roots become compressed. General discomfort or malaise during gout flare-ups.
Diagnostic & Treatment
Diagnosis Path: Diagnosing other secondary gout in the vertebrae involves a combination of clinical evaluation, imaging studies, and laboratory tests. Key steps include: - Medical history assessment to identify underlying causes of secondary gout. - Blood tests measuring serum uric acid levels. - Imaging techniques such as X-rays, MRI, or CT scans to detect urate crystal deposits or signs of inflammation within the vertebrae. - Sometimes, a biopsy or joint fluid analysis may be performed to confirm the presence of urate crystals.
Treatment Protocols: Treatment strategies focus on managing symptoms, lowering uric acid levels, and addressing the underlying causes. Typical approaches include: - Use of medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation. - Colchicine or corticosteroids for flare-up management. - Uric acid-lowering therapies like allopurinol or febuxostat to prevent future attacks. - Lifestyle modifications, including dietary changes to reduce purine intake, limiting alcohol consumption, and maintaining hydration. - Addressing underlying health issues such as kidney disease or medication adjustments to improve uric acid clearance.
Clinical Advice & FAQs
Billing Guidance
Is M10.48 a billable ICD-10 code?
Yes, M10.48 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M10.48?
Clinical documentation must specify the nature of Other secondary gout, vertebrae and any associated comorbidities for accurate reporting.
Cite this Clinical Reference